» Articles » PMID: 36982235

Pivotal Role of Intestinal Microbiota and Intraluminal Metabolites for the Maintenance of Gut-Bone Physiology

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Mar 29
PMID 36982235
Authors
Affiliations
Soon will be listed here.
Abstract

Intestinal microbiota, and their mutual interactions with host tissues, are pivotal for the maintenance of organ physiology. Indeed, intraluminal signals influence adjacent and even distal tissues. Consequently, disruptions in the composition or functions of microbiota and subsequent altered host-microbiota interactions disturb the homeostasis of multiple organ systems, including the bone. Thus, gut microbiota can influence bone mass and physiology, as well as postnatal skeletal evolution. Alterations in nutrient or electrolyte absorption, metabolism, or immune functions, due to the translocation of microbial antigens or metabolites across intestinal barriers, affect bone tissues, as well. Intestinal microbiota can directly and indirectly alter bone density and bone remodeling. Intestinal dysbiosis and a subsequently disturbed gut-bone axis are characteristic for patients with inflammatory bowel disease (IBD) who suffer from various intestinal symptoms and multiple bone-related complications, such as arthritis or osteoporosis. Immune cells affecting the joints are presumably even primed in the gut. Furthermore, intestinal dysbiosis impairs hormone metabolism and electrolyte balance. On the other hand, less is known about the impact of bone metabolism on gut physiology. In this review, we summarized current knowledge of gut microbiota, metabolites and microbiota-primed immune cells in IBD and bone-related complications.

Citing Articles

Gut microbiota and male fertility: A two-sample Mendelian randomization study.

Wang Z, Kang Y Medicine (Baltimore). 2025; 104(8):e41542.

PMID: 39993105 PMC: 11857013. DOI: 10.1097/MD.0000000000041542.


Navigating the gut-bone axis: The pivotal role of Coprococcus3 in osteoporosis prevention through Mendelian randomization.

Ma J, Wang X, Zhou Y, Zhou W, Zhang J, Sun C Medicine (Baltimore). 2024; 103(29):e38861.

PMID: 39029026 PMC: 11398822. DOI: 10.1097/MD.0000000000038861.


Prediction of Osteoporotic Hip Fracture Outcome: Comparative Accuracy of 27 Immune-Inflammatory-Metabolic Markers and Related Conceptual Issues.

Fisher A, Fisher L, Srikusalanukul W J Clin Med. 2024; 13(13).

PMID: 38999533 PMC: 11242639. DOI: 10.3390/jcm13133969.


Gut microbiota, inflammatory factors, and scoliosis: A Mendelian randomization study.

Zhao X, Liu J, Zhang L, Ma C, Liu Y, Wen H Medicine (Baltimore). 2024; 103(24):e38561.

PMID: 38875409 PMC: 11175948. DOI: 10.1097/MD.0000000000038561.


Latest Review Papers in Molecular Microbiology.

Burkovski A Int J Mol Sci. 2023; 24(18).

PMID: 37762293 PMC: 10531291. DOI: 10.3390/ijms241813990.


References
1.
Vicentini F, Keenan C, Wallace L, Woods C, Cavin J, Flockton A . Intestinal microbiota shapes gut physiology and regulates enteric neurons and glia. Microbiome. 2021; 9(1):210. PMC: 8549243. DOI: 10.1186/s40168-021-01165-z. View

2.
Ezzat Y, Hamdy K . The frequency of low bone mineral density and its associated risk factors in patients with inflammatory bowel diseases. Int J Rheum Dis. 2010; 13(3):259-65. DOI: 10.1111/j.1756-185X.2010.01542.x. View

3.
Lucas S, Omata Y, Hofmann J, Bottcher M, Iljazovic A, Sarter K . Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss. Nat Commun. 2018; 9(1):55. PMC: 5754356. DOI: 10.1038/s41467-017-02490-4. View

4.
Hayashi M, Abe K, Fujita M, Okai K, Takahashi A, Ohira H . Association between sarcopenia and osteoporosis in chronic liver disease. Hepatol Res. 2018; 48(11):893-904. DOI: 10.1111/hepr.13192. View

5.
Akdis C . Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions?. Nat Rev Immunol. 2021; 21(11):739-751. DOI: 10.1038/s41577-021-00538-7. View